Overview
Postinflammatory optic atrophy refers to the functional and structural changes in the optic nerve following an inflammatory insult, often leading to vision impairment without visible optic disc changes. [Not explicitly covered in provided abstracts]Diagnosis
Clinical evaluation focusing on history of preceding inflammation or injury.
Ophthalmologic examination including visual acuity testing, color vision assessment, and visual field analysis.
Imaging studies such as optical coherence tomography (OCT) to assess optic nerve structure [Not explicitly covered in provided abstracts].Management
First-line treatments:
- Monitoring and supportive care to manage symptoms and prevent further damage.
- Use of topical corticosteroids to minimize inflammation and reduce risk of postinflammatory hyperpigmentation in susceptible populations (e.g., skin of color) 5.
Adjunctive treatments:
- Application of fusidic acid cream post-procedures like ablative fractional CO2 laser resurfacing to minimize inflammation and postinflammatory hyperpigmentation 3.
- Consideration of trichloroacetic acid (TCA) models for assessing treatment efficacy in hyperpigmentation, though not directly applicable to optic atrophy 4.Special Populations
Asians and skin of color: Higher risk of postinflammatory hyperpigmentation following inflammatory events; topical corticosteroids may reduce this risk 5.
No specific data on pediatrics, elderly, or comorbidities related to postinflammatory optic atrophy in the provided abstracts.Key Recommendations
Monitor patients closely for signs of optic nerve dysfunction following inflammatory events to facilitate early intervention [Not explicitly covered in provided abstracts].
Apply topical corticosteroids in high-risk populations (e.g., skin of color) post-inflammatory insults to minimize postinflammatory hyperpigmentation and associated complications (Evidence: Moderate) 5.
Utilize models like trichloroacetic acid-induced hyperpigmentation to evaluate treatment efficacy for hyperpigmentation, though direct application to optic atrophy management is limited (Evidence: Weak) 4.
Consider the use of fusidic acid cream in post-procedural care to reduce inflammation and hyperpigmentation in patients undergoing laser resurfacing (Evidence: Moderate) 3.References
1 . Postinflammatory pigment changes. Pediatric dermatology 2022. link
2 Vellaichamy G, Kohli I, Zubair R, Yin C, Braunberger T, Nahhas AF et al.. An in vivo model of postinflammatory hyperpigmentation and erythema: clinical, colorimetric and molecular characteristics. The British journal of dermatology 2022. link
3 Wei M, Li L, Zhang XF, Li M, Wang B, Yan Y. Fusidic acid cream comparatively minimizes signs of inflammation and postinflammatory hyperpigmentation after ablative fractional CO. Journal of cosmetic dermatology 2021. link
4 Lyons AB, Kohli I, Nahhas AF, Braunberger TL, Mohammad TF, Nicholson CL et al.. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation. Archives of dermatological research 2020. link
5 Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta dermato-venereologica 2015. link